Article Details
Retrieved on: 2021-03-29 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“We are excited to partner with Lassen and explore the effects of monoclonal antibodies that block IL-11 signaling in our models of IPF,” Hogaboam said.
Article found on: pulmonaryfibrosisnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here